INS and cancer: Identification of insulin as upstream regulator in SCC points out well described relationship between diabetes mellitus and cancers, including lung cancer, and hyperinsulinemia and exogenous insulin and insulin analog therapy were indicated as common risk factors for development of cancer [142].